In 2023, the import of composite diagnostic or laboratory reagents to India was valued at $556.24 million. This marked the beginning of a forecasted upward trend. By the end of 2024, imports are expected to increase to $576.73 million, reflecting a 3.68% year-on-year growth. In 2025, the imports are forecasted to reach $596.8 million, growing by 3.48% from the previous year. The upward trend continues with imports reaching $616.47 million in 2026, growing by 3.29%. This trend sees a continued increase to $635.75 million in 2027, a 3.13% year-on-year growth.
Over the analyzed period from 2023 to 2027, the compound annual growth rate (CAGR) stands at approximately 3.42%. This steady increase indicates a robust growth pattern in the import of these reagents into India.
Future trends to watch for:
- Technological advancements in diagnostic and laboratory reagents, potentially driving demand.
- Regulatory changes in India's import policies impacting the market.
- Shifts in global supply chains due to geopolitical and economic factors.
- Increased demand driven by the expansion of healthcare infrastructure and enhanced diagnostic capabilities.
